TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV

Trial Profile

TS Stratified Chemotherapy and VEGF Inhibition in Non-Squamous Non-Small Cell Lung Cancer - Stage IV

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 10 Oct 2014

At a glance

  • Drugs Bevacizumab (Primary) ; Cisplatin (Primary) ; Pemetrexed (Primary)
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Acronyms SELECT-A
  • Most Recent Events

    • 28 Sep 2013 Status changed from recruiting to withdrawn prior to recruitment as reported by European Clinical Trials Database.
    • 22 Jun 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2011-002145-35).
    • 14 Jun 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top